Under construction – not a live service
Sign in

2025-524751-32-00Not yet recruitingPhase 4

Combined impact of cardiovascular polypill treatment and a specific nurse education program on adherence to therapy in patients with ACS: a randomized study

Source: EU CTIS (euclinicaltrials.eu) · Last updated 30 Mar 2026

Next steps

Brief summary (registry, in English)

To evaluate, through a randomized controlled trial, the potential additive impact of prescribing the cardiovascular polypill at hospital discharge combined with the implementation of a nurse-led education program on therapeutic adherence one year after admission, in patients with acute coronary syndrome (ACS)

Status (registry)
Not yet recruiting
Phase (registry)
Phase 4
Study type
Interventional
Enrollment
216 (estimated)
First submitted
4 Dec 2025
Start date
1 Mar 2026
Lead sponsor
Fundacion Epic
EU CT number
2025-524751-32-00

What you commit to

  • Study type: Interventional · Phase 4
  • Planned participants: 216
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.

Who cannot take part

Copied verbatim from EU CTIS (euclinicaltrials.eu) and grouped by topic. Only the trial team decides who can take part.

Other

  • Contraindication to any of the components of the polypill
  • Refusal or inability to provide informed consent
  • Inability to complete clinical follow-up
  • Patients admitted to long-term care facilities or nursing homes at the time of inclusion and/or during the one-year follow-up

Who the study is looking for

  • Adult patients admitted for acute coronary syndrome (ACS) at the study centers between September 2024 and September 2026. ACS will be defined as chest pain suggestive of ischemia accompanied by electrocardiographic changes indicative of myocardial ischemia (T-wave inversion, ST-segment elevation or depression, new onset left bundle branch block) and/or high-sensitivity troponin elevation above the laboratory reference threshold

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on EU CTIS (euclinicaltrials.eu)

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Bellvitge University HospitalL'hospitalet De LlobregatSpainNot yet recruiting

Are you the coordinator? Confirm the details

This page is information, not medical advice. Discuss any trial with your doctor.